Journalartikel

Jahr der Veröffentlichung: 2021

Zeitschrift: International Journal of Environmental Research and Public Health

Bandnummer: 18

Heftnummer: 16

eISSN: 1660-4601

Open Access Status: Gold

DOI Link: https://doi.org/10.3390/ijerph18168297

Verlag: MDPI

Abstract: 
Right ventricular (RV) function is the main determinant of the outcome of patients with pulmonary hypertension (PH). RV dysfunction develops gradually and worsens progressively over the course of PH, resulting in RV failure and premature death. Currently, approved therapies for the treatment of left ventricular failure are not established for the RV. Furthermore, the direct effects of specific vasoactive drugs for treatment of pulmonary arterial hypertension (PAH, Group 1 of PH) on RV are not fully investigated. Pulmonary artery banding (PAB) allows to study the pathogenesis of RV failure solely, thereby testing potential therapies independently of pulmonary vascular changes. This review aims to discuss recent studies of the mechanisms of RV remodeling and RV-directed therapies based on the PAB model.

Harvard-Zitierstil: Mamazhakypov, A., Sommer, N., Assmus, B., Tello, K., Schermuly, R., Kosanovic, D., et al. (2021) Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model, International Journal of Environmental Research and Public Health, 18(16), Article 8297. https://doi.org/10.3390/ijerph18168297

APA-Zitierstil: Mamazhakypov, A., Sommer, N., Assmus, B., Tello, K., Schermuly, R., Kosanovic, D., Sarybaev, A., Weissmann, N., & Pak, O. (2021). Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model. International Journal of Environmental Research and Public Health. 18(16), Article 8297. https://doi.org/10.3390/ijerph18168297